ECCO Highlights

flipper_slider

Editor's Choice

Axel Merseburger - Filmed at the ECC 2015, Vienna Part 1/3: Axel Merseburger discusses approaches to prevent relapse after ADT in patients with prostate cancer.

ECCO Highlights Videos

Martin Schuler discusses the latest analyses from the LUX-Lung 3, LUX-Lung 6 and LUX-Lung 7 studies.
Yvonne Brandberg discusses the PANTHER trial and the impact of tailored dose-dense chemotherapy on quality of life. Disclosures: Yvonne Brandberg has nothing to disclose in relation to this video
Vytenis Andriukaitis talks about the unmet needs in cancer care in Europe and exciting new developments in cancer vaccines. Disclosures: Vytenis Andriukaitis has nothing to disclose in relation to this video.
Professor Gonzalez-Moreno discusses ESSO and their future collaborations with ECCO to fight cancer together. Disclosures: Professor Gonzalez-Moreno has nothing to disclose in relation to this video.
Professor Gonzalez-Moreno discusses the role of surgery in the multidisciplinary management of cancers and the main obstacles faced by a multidisciplinary team. Disclosures: Professor Gonzalez-Moreno has nothing to disclose in relation to this video.
Karim Fizazi - Filmed at the ECC 2015, Vienna Part 2/2: Karim Fizazi discusses the impact of recent research into prognostic and predictive tests in prostate cancer on the clinical outcomes.
Karim Fizazi - Filmed at the ECC 2015, Vienna Part 1/2: Following the recent approval of several new therapeutic approaches, Karim Fizazi discusses the challenges of deciding which new treatment approach to use, and when.
Federico Cappuzzo - Filmed at the ECC 2015, Vienna Part 3/3: Federico Cappuzzo highlights the greatest unmet needs in lung cancer therapy.
Federico Cappuzzo - Filmed at the ECC 2015, Vienna Part 2/3: Federico Cappuzzo reviews the latest research and developments in the treatment of NSCLC.
Federico Cappuzzo - Filmed at the ECC 2015, Vienna Part 1/3: Federico Cappuzzo discusses how understanding treatment resistance to EGFR inhibitors could impact future treatment strategies in NSCLC.
Bernardo Rapoport - Filmed at the ECC 2015, Vienna Part 4/4: Bernardo Rapoport highlights the new key data on agents targeting molecular signalling pathways associated with chemotherapy-induced nausea and vomiting.
Bernardo Rapoport - Filmed at the ECC 2015, Vienna Part 3/4: Bernardo Rapoport highlights the new key data on agents targeting molecular signalling pathways associated with chemotherapy-induced nausea and vomiting.
Bernardo Rapoport - Filmed at the ECC 2015, Vienna Part 2/4: Bernardo Rapoport discusses the clinical impact of NK1-receptor antagonists in reducing chemotherapy-induced nausea and vomiting.
Bernardo Rapoport - Filmed at the ECC 2015, Vienna Part 1/4: Bernardo Rapoport discusses the role of rolapitant in reducing chemotherapy-induced nausea and vomiting after cisplatin-based therapy.
Paulo Ascierto - Filmed at the ECC 2015, Vienna Part 3/3: Paulo Ascierto discusses the the next steps for PD-1 pathway immune checkpoint inhibitors.